Taken together, these results suggest that GRAMD1B is expressed and modulated in macrophages/monocytes and astrocytes in inflammatory conditions, consistent with its potential role in MS pathogenesis. The gene discussed is GRAMD1B; the disease is myeloid sarcoma.